Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134570) titled 'A Randomized Controlled Study of Different Dydrogesterone Regimens for the Treatment of Menorrhagia' on Oct. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University People's Hospital
Condition:
menorrhagia
Intervention:
Treatment in the luteal phase:Starting from the 14th day of the menstrual cycle, administer dydrogesterone at a dose of 10 mg twice daily for 10 consecutive days. The treatment sho
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-20
Target Sample Size: Treatment in the luteal phase:50;Full-cycle treatment:50;
Count...